Cannabis
Montana Bill To Implement Marijuana Legalization Heads To Governor’s Desk (Marijuana Moment)
Texas Lawmakers Approve Marijuana And Psychedelics Reform Bills (Marijuana Moment)
Philadelphia: City Council Votes to Prohibit Pre-Employment Drug Screening for Cannabis (NORML)
GOP Congressman’s Bill Would Protect Marijuana Consumers’ 2nd Amendment Rights (Marijuana Moment)
Minnesota Marijuana Legalization Bill Clears Ninth House Committee On Path To Floor (Marijuana Moment)
Louisiana Lawmakers Approve Marijuana Legalization Bill In Committee (Marijuana Moment)
South Dakota Supreme Court Hears Arguments in Litigation Challenging State’s Voter-Approved Marijuana Legalization Initiative (NORML)
Bolsonaro’s Cabinet Crusade Against Cannabis is Racist and Classist (TalkingDrugs)
Pennsylvania Marijuana Poll Shows Highest-Ever Support For Legalization (Marijuana Moment)
LSD
CEO Of $2 Billion Startup Fired After Experimenting With LSD At Work (Forbes)
Magic Mushrooms
Maine Proposal Would Legalize Psilocybin Mushroom Therapy For Adults, No Medical Diagnosis Needed (Marijuana Moment)
How an expert psilocybin tester chooses award-winning mushrooms (Inverse)
Hawaii Legislature Seeks Marijuana Exemption From DEA While Senate Requests Legal Psilocybin Plan (Marijuana Moment)
Revive Therapeutics Files for FDA Orphan Drug Designation for Psilocybin in Traumatic Brain Injury (Psilocybin Alpha)
Numinus Announces Phase 1 Clinical Trial of Natural Psilocybin Mushroom Extraction Prepared at Company Lab (Psilocybin Alpha)
Red Light Holland and Halo Collective Create Red Light Oregon, Inc. – Forwarding Intentions to Enter Oregon Medicinal Psychedelic Market (Psilocybin Alpha)
MDMA
MDMA-Assisted Therapy for Alcohol Addiction (Spirit Pharmacist)
Bupropion and MDMA, Risky Combination? (Spirit Pharmacist)
DMT
PharmaDrug Announces First FDA Orphan Drug Designation of DMT for the Prevention of Ischemia-Reperfusion Injury from Organ Transplantation (Psilocybin Alpha)
Ayahuasca
Spain’s (Second to) Last Ayahuasca Trial (ICEERS)
Novel Psychoactive Substances
Non-hallucinogenic psychedelics: scientists close in on compound (The Guardian)
Mindset Pharma Announces Positive Preclinical Results of Its Proprietary Next Generation DMT & 5-MeO-DMT Compounds (Psilocybin Alpha)
Eliminating Bad Trips Through Minor Tryptamines (Truffle Report)
Cybin Selects Alcohol Use Disorder Indication for Psychedelic Molecule CYB003 (Psilocybin Alpha)
Synthetic Cannabinoids
'Rising rates' of synthetic marijuana in Iowa prisons prompts investigation (Des Moines Register)
Ketamine
Bill to regulate ketamine used during police calls passes House committee (Sentinel Colorado)
Bexson Biomedical Granted USPTO Patent On Proprietary Ketamine Formulation (Psilocybin Alpha)
PharmaTher Expands Patent Portfolio with Filing of U.S. Patent Application for Ketamine and Repurposing of Psychedelics with panaceAI™ (Psilocybin Alpha)
Miscellaneous
MindMed Becomes Second Psychedelic Drug Development Company to List on the Nasdaq (Psilocybin Alpha)
Scientists are Using AI to Develop New Psychedelic Drugs (DoubleBlind)
UCSF Launches New Psychedelic Research Division (Benzinga)
Drug Possession To Be A Misdemeanor—For Now—Under Washington State Bill Headed To Governor’s Desk (Marijuana Moment)
Psychedelic drugs without the trip? This sensor could help seek them out (Nature)
Should Society Legalize Psychedelics? A Breakdown of the Intelligence Squared Debate (Psychedelics Today)
Native Tribes Should Have More Say in the Psychedelic Movement (Green Entrepreneur)
This Brain Imaging Device Could Impact Understanding Psychedelic Trips (Healing Maps)
COMPASS Pathways announces pricing of public offering (Psilocybin Alpha)
How To Talk With Your Kids About Psychedelics (Psychedelics Today)
Why Psychedelics, Big in the 1960s, Are Drawing New Interest Now (Bloomberg)
Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.
Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalog how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.